second
A groundbreaking experimental drug, lepodisiran from Eli Lilly, shows promising results in reducing lipoprotein(a) or Lp(a)—a cholesterol variant linked to heart attacks—by an astounding 94% with a single injection. Benefits …
Eli Lilly’s New Drug Dramatically Reduces Heart Attack Risk Through Lp(a) Management Read More
A recent study published in The Lancet has revealed that Ozempic, known generically as semaglutide, can aid individuals with type 2 diabetes suffering from peripheral artery disease (PAD). This circulatory …
Ozempic: A Game Changer for Diabetes Patients Struggling with Walking Read More
The tragic demise of 28-year-old Katie Donnell, a teacher from Florida, has ignited concerns regarding caffeine’s role in heart health. Her mother linked Katie’s heart attack to her routine of …
Caffeine and Heart Health: Risks Emerging from Tragic Case of a Young Teacher Read More
Recent findings highlight that heart health risk factors pose a more significant threat to women than men. Women suffering from poor health face nearly five times the heart disease risk, …
Women Face Greater Heart Health Risks Than Men Read More